✦ LIBER ✦

Safety, Tolerability, and Efficacy of Hizentra Over An Extended Period for the Treatment of Primary Immunodeficiency Disease

✍ Scribed by Nelson, R.P.; Melamed, I.; Stein, M.R.; Wasserman, R.L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy, safety, and tolerabi

✍ Jolles, Stephen; Borte, Michael; Nelson, Robert P.; Rojavin, Mikhail; Bexon, Mar 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Safety, Tolerability, and Efficacy Of Hi

✍ Imai, Kohsuke; Kanegane, Hirokazu; Yamada, Masafumi; Takada, Hidetoshi; Ariga, T 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Patients with primary immunodeficiency r

✍ Christopher A. Jones; Mikhail Rojavin; Jeffrey S. Baggish 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

Long-Term Efficacy and Tolerability of 2

✍ Borte, Michael; Wasserman, Richard L.; Rojavin, Mikhail; Bexon, Martin; Jolles, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Efficacy and safety of an extended-relea

✍ Christie M Ballantyne; James McKenney; Bruce S Trippe 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 148 KB

P-201: An investigation into the safety,

✍ Joshua Shua-Haim; Dorina Hajnaj; Avraham Tuvy; Syed Zaidi; Paul Lee 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 45 KB